Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
Complications arising from antibiotic-resistant bacteria are becoming one of the key issues in modern medicine. Members of drug-resistant Enterobacteriaceae spp. include opportunistic pathogens (e.g., Salmonella spp.) that are among the leading causes of morbidity and mortality worldwide. Overgrowth of these bacteria is considered a hallmark of intestinal dysbiosis. Microcins (small antimicrobial peptides) produced by some gut commensals can potentially cure these conditions by inhibiting these pathogens and have been proposed as a viable alternative to antibiotic treatment. In this proof-of-concept work, we leverage this idea to develop a genetically engineered prototype probiotic to inhibit Salmonella spp. upon exposure to tetrathionate, a molecule produced in the inflamed gut during the course of Salmonella infection. We developed a plasmid-based system capable of conferring the ability to detect and utilize tetrathionate, while at the same time producing microcin H47. We transferred this plasmid-based system to Escherichia coli and demonstrated the ability of the engineered strain to inhibit growth of Salmonella in anaerobic conditions while in the presence of tetrathionate, with no detectable inhibition in the absence of tetrathionate. In direct competition assays between the engineered E. coli and Salmonella, the engineered E. coli had a considerable increase in fitness advantage in the presence of 1 mM tetrathionate as compared to the absence of tetrathionate. In this work, we have demonstrated the ability to engineer a strain of E. coli capable of using an environmental signal indicative of intestinal inflammation as an inducing molecule, resulting in production of a microcin capable of inhibiting the organism responsible for the inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, coupling gene expression to biosensors of reactive oxygen and nitrogen species for the treatment of inflammatory bowel disease may help deliver effectors specifically where activity is beneficial7,28.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other groups have reported the successful production of antimicrobial peptides from EcN that are effective for significantly decreasing murine colonization by Enterococcal species36 or Salmonella typhimurium28.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 9,996
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Lenski, R. E., Rose, M. R., Simpson, S. C., & Tadler, S. C. (1991) · The American Naturalist · doi:10.1086/285289 · Cited by 1,580
Gut inflammation provides a respiratory electron acceptor for Salmonella
Winter, S. E., Thiennimitr, P., Winter, M. G., Butler, B. P., Huseby, D. L., Crawford, R. W., Russell, J. M., Bevins, C. L., Adams, L. G., Tsolis, R. M., et al. (2010) · Nature · doi:10.1038/nature09415 · Cited by 1,290
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut
Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D., et al. (2013) · Science · doi:10.1126/science.1232467 · Cited by 1,019
Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Sassone-Corsi, M., Nuccio, S.-P., Liu, H., Hernandez, D., Vu, C. T., Takahashi, A. A., Edwards, R. A., & Raffatellu, M. (2016) · Nature · doi:10.1038/nature20557 · Cited by 549
Hwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W. (2017) · Nature Communications · doi:10.1038/ncomms15028 · Cited by 472
Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation
Riglar, D. T., Giessen, T. W., Baym, M., Kerns, S. J., Niederhuber, M. J., Bronson, R. T., Kotula, J. W., Gerber, G. K., Way, J. C., & Silver, P. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3879 · Cited by 426
Cited by
Items 101–143 of 143
Repurposing bacterial secretion systems for the design of living therapeutics
Robertin, S., & Lesser, C. F. (2026) · Current Opinion in Microbiology · doi:10.1016/j.mib.2026.102726 · Cited by 3
Cellular membrane protein MipA from E.coli Nissle 1917 protects against Salmonella infection
Xiang, Y., Peng, H., Li, Y., Wen, H., Li, N., Liu, X., Yuan, G., Shi, Y., & Huang, S. (2026) · The ISME Journal · doi:10.1093/ismejo/wrag054 · Cited by 3
Engineering Logical Inflammation Sensing Circuit for Modulating Gut Conditions
Merk, L. N., Shur, A., Pandey, A., Murray, R. M., & Green, L. N. (2020) · CaltechAUTHORS (California Institute of Technology) · Cited by 3
Fields, B. D., Pascal, D. G., Rando, O. K., Huddleston, M., Ingram, K., Hopton, R., Grogg, M. W., Nelson, M., & Voigt, C. A. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00690 · Cited by 2
Microbes in regenerative medicine: A narrative review
Varaganti, V., Avr, V., Vedanth, N. P., Pusuluri, R. C., Panniru, A. C., Potluri, S., & Kandi, V. (2025) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-25-00026 · Cited by 3
Wang, Z.-R., Zeng, C., Yan, Z., Xu, Z.-F., & Feng, D. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1786444 · Cited by 2
Synthetic gene circuits for higher-order information processing
Sarkar, K., & Bagh, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824469-2.00003-8 · Cited by 2
Probiotics in Action: Enhancing Immunity and Combatting Diseases for Optimal Health
Singh, A., Mazumder, A., Das, S., Tyagi, P. K., & Chaitanya, M. (2024) · Journal of Natural Remedies · doi:10.18311/jnr/2024/35894 · Cited by 2
Ec W: A Novel Narrow-Spectrum Class IIb Microcin from Escherichia coli
Bhattarai, S. K., Bucci, V., & Mortzfeld, B. M. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10549-8 · Cited by 2
Self-citationMortzfeld, B. M., Bhattarai, S. K., & Bucci, V. (2024) · eLife · doi:10.7554/elife.102912.1 · Cited by 2
Self-citationSingh, R. P., Kolton, M., Boker, M., David, N. B., Green, S. J., Helman, A., Tirosh, O., & Hayouka, Z. (2022) · Exploration of Digestive Diseases · doi:10.37349/edd.2022.00009 · Cited by 1
Metagenomics-guided reengineering of the gut microbiome
Dhotre, D. P., & Karmarkar, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91631-8.00011-1 · Cited by 2
Mazzolini, R., Garrido, V., Gómez, A.-C., Collantes, M., Grilló, M. J., Piñero‐Lambea, C., Gibert, I., Yero, D., & Lluch‐Senar, M. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00835-2 · Cited by 1
Cytrynbaum, E. G., & McClean, M. N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115740 · Cited by 1
Advancements in technology for developing recombinant live biotherapeutics
Verma, J. K., & Paul, D. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.01.006 · Cited by 1
Biological treatments for zoonotic salmonellosis: an evolving therapeutic landscape
Ma, S., Liu, X., Shen, M., Deng, S., Ding, C., Yang, X., Zhang, L., & Jia, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1769519 · Cited by 1
An Engineered Variant of E. coli Nissle 1917 with Enhanced Transformation Efficiency and Robustness
Gudi, C. R., Neilson, W. J., & Mansell, T. J. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00852 · Cited by 2
The role of probiotics as gastrointestinal infections treatment and prophylaxis: A review
Leite, G. G. V. R., & Damasceno, C. A. V. (2021) · Medical Science and Discovery · doi:10.36472/msd.v8i9.601 · Cited by 1
Exploring the Potential of Microbial Engineering: The Prospect, Promise, and Essence
Patra, S. D., Arunima, A., & Suar, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_1
Antibacterial microcins, class II: A review
Блинкова, Л. П., Ml, A., & AIu, M. (2023) · Epidemiology and Infectious Diseases · doi:10.17816/eid321851
Designer Probiotics and Postbiotics
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_25
Synthetic Biology Toolbox: Developing Microbial Therapeutics
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_22
Genetic Engineering and Genome Editing of Probiotic Microbes
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_24
Ali, A., & Mousa, W. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_15
Boss, A., Toepfer, S., Erb, M., & Machado, R. A. R. (2025) · BMC Genomics · doi:10.1186/s12864-025-12067-x
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558360
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558342
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558351
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558366
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. Ø., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558336
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558354
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558363
Exploiting the human gut microbiome for novel therapeutics
Chang, E. (2022) · Journal of High School Science · doi:10.64336/001c.38540
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558348
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558357
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558345
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558339
Microbial Biotechnology in Medicine
Addington, E., Gannon, A. D., Larcombe, D. E., Lawaetz, A. C., McHugh, R. E., Vahtokari, S., & Munnoch, J. (2026) · Progress in molecular and subcellular biology · doi:10.1007/978-3-032-11438-9_7
Immunotherapeutic Applications of Probiotics in Infectious Diseases Management: A Scoping Review
Adejumo, S. A., Ojiako, C. M., Das, P., Onyia, F. C., Okafor, M. N., Chukwuma, I. F., Hampton‐Marcell, J., & Oli, A. N. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/8197569 · Cited by 1
The role of non-coding RNAs (ncRNA) in the pathogenesis of Clostridioides difficile
Piattelli, E. (2023) · theses.fr (ABES) · doi:10.70675/430fbe25ze30az4c99z8defz8d76a374d4c5
Self-citationTarantino, M., Ippolito, D., Barbieri, G., Petrucci, P., Tammaro, A., Tassinari, R., Maranghi, F., Michetti, E., Ammendola, S., Francia, M., et al. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1816390
Tyagi, V., Kumar, A., Thapliyal, N., Rautela, I., Devi, D., Mathpal, P., Sahni, S., Garg, V. K., & Choudhary, R. K. (2026) · Applied Microbiology · doi:10.3390/applmicrobiol6090103
Xu, J., Qi, Q., & Wang, Q. (2026) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2026.09.006
Metadata
- Authors
- Palmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V.
- Affiliations
- University of Massachusetts Dartmouth (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Bucci, Vanni
- Venue
- ACS Infectious Diseases
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-09-20
- Volume
- 4
- Issue
- 1
- Pages
- 39-45
- ISSN
- 2373-8227 (ISSN-L)
- PMC
- PMC5766358
- OpenAlex
- W2755677477
- Cited by
- 133
- References
- 30
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 23 · 2023: 19 · 2022: 19 · 2021: 12 · 2020: 17 · 2019: 6 · 2018: 6
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- ACS Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Division of Biological Infrastructure (1458347)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK056754)
- National Institute of Allergy and Infectious Diseases (R15-AI112985-01A1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- engineered probiotics, Salmonella, tetrathionate, antimicrobial peptides, Escherichia coli, intestinal inflammation, antibiotic resistance, gut dysbiosis, competition assay, anaerobic conditions
- MeSH terms
- Antibiosis, Genetic Engineering, Peptides, Plasmids, Salmonella, Tetrathionic Acid, Probiotics, Gene Order, Antimicrobial Cationic Peptides, Disk Diffusion Antimicrobial Tests
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.